Dr. Maria Fardis | President & CEO |
Tim Morris | CFO |
Mark Breidenbach | Oppenheimer |
Madhu Kumar | B. Riley FBR |
Biren Amin | Jefferies |
Good afternoon and welcome to the Iovance Biotherapeutics First Quarter 2018 Financial Results Conference Call. All participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the Company's request.
Now, I would like to turn the conference over to Mr.